EGFR and neoplasm: As shown in Table 4, the rs3200401 dominant model (CC versus CT+TT) was significantly associated with MALAT1 genotypes and EGFR wild-type at tumor stages (p=0.016), but not associated with tumor T status, lymph node status, distant metastasis and cell differentiation (Table 4).